Science Explorer Back to mapMap
Institution · Ferrarotto Hospital

Most cited papers from Ferrarotto Hospital

What are the most cited papers from Ferrarotto Hospital?

The most cited paper from Ferrarotto Hospital is "Incidence and Predictors of Early and Late Mortality After Transcatheter Aortic Valve Implantation in 663 Patients With Severe Aortic Stenosis" (Corrado Tamburino, Davide Capodanno, Angelo Bruno Ramondo et al., 2011), with 1,127 citations. Next come "BRAF Mutations in Hairy-Cell Leukemia" (1,029) and "Cardiovascular Events and Intensity of Treatment in Polycythemia Vera" (845).

Showing 50 of 59 papers. Every paper with more than 176 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Incidence and Predictors of Early and Late Mortality After Transcatheter Aortic Valve Implantation in 663 Patients With Severe Aortic Stenosis Corrado Tamburino, Davide Capodanno, Angelo Bruno Ramondo et al. · Circulation Open access 11 Jan 2011 1,127
2 BRAF Mutations in Hairy-Cell Leukemia Enrico Tiacci et al. · New England Journal of Medicine Open access 11 Jun 2011 1,029
3 Cardiovascular Events and Intensity of Treatment in Polycythemia Vera Roberto Marchioli et al. · New England Journal of Medicine Open access 8 Dec 2012 845
4 Percutaneous Mitral Valve Interventions in the Real World Francesco Maisano, Olaf Walter Franzen, Stephan Ernst Baldus et al. · Journal of the American College of Cardiology Open access 7 Jun 2013 838
5 Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study Michèle Cavo et al. · The Lancet Dec 2010 825
6 Autologous Transplantation and Maintenance Therapy in Multiple Myeloma Antonio Palumbo et al. · New England Journal of Medicine Open access 3 Sep 2014 786
7 Incidence, Predictors, and Outcomes of Aortic Regurgitation After Transcatheter Aortic Valve Replacement Ganesh Athappan, Eshan A. Patvardhan, Emin Murat Tuzcu et al. · Journal of the American College of Cardiology Open access Apr 2013 782
8 Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Davide Capodanno, Anna Sonia Petronio, Bernard Prendergast et al. · European Heart Journal Open access 19 May 2017 531
9 Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry Lucas V.A. Boersma, Lucas V.A. Boersma, Boris Schmidt et al. · European Heart Journal Open access 27 Jan 2016 526
10 Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis Sung-Han Yoon et al. · Journal of the American College of Cardiology Open access 18 Mar 2017 492
11 Sirolimus- vs Paclitaxel-Eluting Stents in De Novo Coronary Artery Lesions Marie-Claude Morice, Antonio Hugo Bezerra Colombo, Bernhard Meier et al. · JAMA Open access 21 Feb 2006 458
12 Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry Davide Capodanno, Tommaso Gori, HOLGER M. NEF et al. · EuroIntervention Feb 2015 454
13 Percutaneous Mitral Valve Edge-to-Edge Repair Georg Nickenig et al. · Journal of the American College of Cardiology Open access 25 Aug 2014 429
14 Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry Henrique Barbosa Ribeiro et al. · European Heart Journal Open access 19 Jul 2017 426
15 Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome–positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol Marco Vignetti, Paola Fazi, Giuseppe G. Cimino et al. · Blood Open access 9 Jan 2007 375
16 A Randomized Multicenter Study Comparing a Paclitaxel Drug-Eluting Balloon With a Paclitaxel-Eluting Stent in Small Coronary Vessels Azeem Latib, Antonio Hugo Bezerra Colombo, Fausto Castriota et al. · Journal of the American College of Cardiology Open access 14 Nov 2012 364
17 Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia Enrico Tiacci et al. · New England Journal of Medicine Open access 10 Sep 2015 349
18 Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group Francesco Lo‐Coco et al. · Blood 20 Jul 2010 346
19 Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Disease Darren Mylotte et al. · Journal of the American College of Cardiology Open access Dec 2014 343
20 Association Between Transcatheter Aortic Valve Replacement and Subsequent Infective Endocarditis and In-Hospital Death Ander Regueiro et al. · JAMA Open access 13 Sep 2016 342
21 In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry Alfredo Ruggero Galassi et al. · EuroIntervention Aug 2011 342
22 Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation Sung-Han Yoon et al. · Journal of the American College of Cardiology Open access 27 Nov 2017 339
23 MYH9-Related Disease Marco Seri et al. · Medicine Open access May 2003 315
24 Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma Michèle Cavo et al. · Blood Open access 13 Apr 2012 311
25 Classification of coronary artery bifurcation lesions and treatments: Time for a consensus! Yves Louvard et al. · Catheterization and Cardiovascular Interventions Open access 5 Nov 2007 309
26 Permanent Pacemaker Implantation After Transcatheter Aortic Valve Implantation Marina Ureña et al. · Circulation Open access 26 Dec 2013 307
27 Safety and Efficacy of the Subclavian Approach for Transcatheter Aortic Valve Implantation With the CoreValve Revalving System Anna Sonia Petronio, Marco De Carlo, Francesco Bedogni et al. · Circulation Cardiovascular Interventions Open access 7 Jul 2010 293
28 Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide Alessandra Larocca et al. · Blood 12 Aug 2011 289
29 Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis Gian Paolo Ussia et al. · European Heart Journal 12 Jan 2012 284
30 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascu Gregory Y H Lip et al. · EP Europace Open access 14 Jul 2018 282
31 M2 Macrophages Phagocytose Rituximab-Opsonized Leukemic Targets More Efficiently than M1 Cells In Vitro Marzia Leidi, Elisa Gotti, Luca Leonardo Bologna et al. · The Journal of Immunology Open access 19 Mar 2009 271
32 Pulmonary Hypertension in Heart Failure. Epidemiology, Right Ventricular Function, and Survival Mario S. Gerges, Christian Gerges, Anna-Maria Pistritto et al. · American Journal of Respiratory and Critical Care Medicine Open access 16 Jul 2015 270
33 Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients Francesca Gay et al. · Blood Open access 12 Jan 2011 267
34 Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population Fabio Efficace et al. · Blood 13 Jul 2011 262
35 Dual Antiplatelet Therapy Versus Aspirin Alone in Patients Undergoing Transcatheter Aortic Valve Implantation Gian Paolo Ussia, Marilena Scarabelli, Massimiliano Mulè et al. · The American Journal of Cardiology 11 Sep 2011 260
36 A Bicuspid Aortic Valve Imaging Classification for the TAVR Era Hasan Jilaihawi et al. · JACC. Cardiovascular imaging Open access Jul 2016 256
37 Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage Marco Ladetto et al. · Blood Feb 2008 253
38 Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting Corrado Tamburino, Gian Paolo Ussia, Francesco Maisano et al. · European Heart Journal Open access 18 Mar 2010 247
39 Revisiting Sex Equality With Transcatheter Aortic Valve Replacement Outcomes Stephen A. O’Connor, Marie‐Claude Morice, Martine Gilard et al. · Journal of the American College of Cardiology Open access Jul 2015 247
40 Late Cardiac Death in Patients Undergoing Transcatheter Aortic Valve Replacement Marina Ureña et al. · Journal of the American College of Cardiology Open access Feb 2015 237
41 5-Year Outcomes After Transcatheter Aortic Valve Implantation With CoreValve Prosthesis Marco Barbanti et al. · JACC: Cardiovascular Interventions Open access 24 Jun 2015 233
42 Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement Richard J. Jabbour et al. · Journal of the American College of Cardiology Open access Apr 2018 230
43 Transcatheter Aortic Valve Replacement With Early- and New-Generation Devices in Bicuspid Aortic Valve Stenosis Sung-Han Yoon et al. · Journal of the American College of Cardiology Open access Sep 2016 228
44 Usefulness of the SYNTAX Score for Predicting Clinical Outcome After Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease Davide Capodanno, M. Salvo, Glauco Cincotta et al. · Circulation Cardiovascular Interventions Open access Jul 2009 222
45 GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia Adriano Venditti et al. · Blood Open access 8 Aug 2019 221
46 Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials Sara Bringhen et al. · Haematologica ReviewOpen access 26 Feb 2013 218
47 Obesity and reduction of the response rate to anti–tumor necrosis factor α in rheumatoid arthritis: An approach to a personalized medicine Elisa Gremese, Antonio Carletto, Melissa Padovan et al. · Arthritis Care & Research Open access 20 Nov 2012 213
48 Morphine Is Associated With a Delayed Activity of Oral Antiplatelet Agents in Patients With ST-Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Guido Parodi, Benedetta Bellandi, Ioanna Xanthopoulou et al. · Circulation Cardiovascular Interventions 2015 212
49 Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study Axel Hans-Peter Linke et al. · European Heart Journal Open access 28 Mar 2014 206
50 Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery in Left Main Coronary Artery Disease Davide Capodanno, Gregg W. Stone, Marie Claude Morice et al. · Journal of the American College of Cardiology Open access Sep 2011 201

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.